HLA-DRB1 genes and disease severity in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 39, Issue 11, 1996, Pages 1802-1807

  Reveille, John D ^a   Alarcón, Graciela S ^b,k   Fowler, Sarah E ^c   Pillemer, Stanley R ^d   Neuner, Rosemarie ^e   Clegg, Daniel O ^f   Mikhail, Isis S ^b   Trentham, David E ^g   Leisen, James C C ^h   Bluhm, Gilbert ^h   Cooper, Sheldon M ⁱ   Duncan, Howard ^h   Tuttleman, Marilyn ^d   Heyse, Stephen P ^d   Sharp, John T ^j   Tilley, Barbara ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Henry Ford Health Science Center   (United States)

^d NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h HENRY FORD HOSPITAL   (United States)

ⁱ UNIVERSITY OF VERMONT   (United States)

^j Tifton Medical Center   (United States)

^k University of Alabama at Birmingham   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DQ ANTIGEN; HLA DR ANTIGEN; RHEUMATOID FACTOR;

ALLELE; ARTHROPATHY; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GENE DOSAGE; GENOTYPE; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ANTI-BACTERIAL AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; EPITOPES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; MINOCYCLINE; MULTICENTER STUDIES; MULTIVARIATE ANALYSIS; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 10344252777     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391105     Document Type: Article

References (19)

1. Willkens RF, Nepom GT, Marks CR, Nettles JW, Nepom BS: Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians: further evidence for the "shared epitope" hypothesis. Arthritis Rheum 34:43-47, 1991
2. De Vries N, Ronningen KS, Tilanus MG, Bouwens-Rombous A, Segal R, Egelund T, Thorsby E, van de Putte LBA, Brautban C: HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens 41:26-30, 1993
3. De Juan MD, Belmonte I, Barado J, Martinez-Laso J, Figueroa M, Arnaiz-Villena A, Cuadrado E: Differential associations of HLA-DR antigens with rheumatoid arthritis (RA) in Basques: high frequency of DR1 and DR10 and lack of association with HLA-DR4 of any of its subtypes. Tissue Antigens 43:320-323, 1994
4. Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213, 1987
5. Weyand CM, Hicok KC, Conn DL, Goronzy JJ: The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117:801-806, 1992
6. Nepom GT, Nepom BS: Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum Dis Clin North Am 18:785-792, 1992
7. Goodman SN, Berlin JA: The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med 121:200-206, 1994
8. Toda Y, Minamikawa Y, Akagi S, Sugano H, Mori Y, Nishimura H, Arita S, Sugino Y, Ogawa R: Rheumatoid-susceptible alleles of HLA-DRB1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA. Ann Rheum Dis 53:587-592, 1994
9. Jawaheer D, Thomson W, MacGregor AJ, Carthy D, Davidson J, Dyer PA, Silman AJ, Oilier WER: "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 37:681-686, 1994
10. Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, Birley A, Emery P: Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 37:1166-1170, 1994
11. Weyand CM, Goronzy JJ: HLA-DRB1 alleles as severity markers in rheumatoid arthritis. Bull Rheum Dis 43:5-8, 1994
12. Weyand CM, McCarthy TG, Goronzy JJ: Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 95:2120-2126, 1995
13. Tilley BC, Alarcón GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, Clegg DO, Leisen JCC, Buckley L, Cooper SM, Duncan H, Pillemer SR, Tuttleman M, Fowler SE, for the MIRA Trial Group: Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial. Ann Intern Med 122:81-89, 1995
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
15. Bluhm GB, Sharp JT, Tilley B, Rusinova M, Alarcón GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, Clegg DO, Leisen JCC, Buckley L, Cooper SM, Duncan H, Pillemer SR, Tuttleman M, Fowler SE: Radiographic results from the minocycline in rheumatoid arthritis trial (MIRA) (abstract). Arthritis Rheum 37 (Suppl 9):S338, 1994
16. Reveille JD, Durban E, MacLeod-St. Clair MJ, Goldstein R, Moreda R, Altman RD, Arnett FC: Association of amino acid sequences in the HLA-DQB1 first domain with the antitopoisomerase I: autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 90:973-980, 1992
17. Harris EDJ: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322:1277-1289, 1990
18. Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS: HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks: the HLA-DRβ shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 35:749-755, 1992
19. McDaniel DO, Alarcón GS, Pratt PW, Reveille JD: Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope). Ann Intern Med 123:181-187, 1995